Barrington Research Maintains Outperform on Concentrix, Raises Price Target to $62

Benzinga · 06/27 13:41
Barrington Research analyst Vincent Colicchio maintains Concentrix (NASDAQ:CNXC) with a Outperform and raises the price target from $54 to $62.